[{"id":"189c84d8-9170-41ee-88a7-ba2d750c2705","acronym":"PRISM-MEL-301","url":"https://clinicaltrials.gov/study/NCT06112314","created_at":"2023-11-01T15:12:45.028Z","updated_at":"2024-07-02T16:34:26.248Z","phase":"Phase 3","brief_title":"IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)","source_id_and_acronym":"NCT06112314 - PRISM-MEL-301","lead_sponsor":"Immunocore Ltd","biomarkers":" BRAF • HLA-A","pipe":" | ","alterations":" BRAF mutation • BRAF V600 • HLA-A*02","tags":["BRAF • HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF mutation • BRAF V600 • HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdualag (nivolumab/relatlimab-rmbw) • brenetafusp (IMC-F106C) • relatlimab (BMS-986016)"],"overall_status":"Recruiting","enrollment":" Enrollment 680","initiation":"Initiation: 12/18/2023","start_date":" 12/18/2023","primary_txt":" Primary completion: 12/01/2026","primary_completion_date":" 12/01/2026","study_txt":" Completion: 12/01/2027","study_completion_date":" 12/01/2027","last_update_posted":"2024-06-13"},{"id":"68a67f53-3f78-4080-af42-75466b7cacd6","acronym":"","url":"https://clinicaltrials.gov/study/NCT04262466","created_at":"2021-01-18T20:42:48.114Z","updated_at":"2024-07-02T16:35:12.070Z","phase":"Phase 1/2","brief_title":"Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors","source_id_and_acronym":"NCT04262466","lead_sponsor":"Immunocore Ltd","biomarkers":" HLA-A • PRAME","pipe":" | ","alterations":" HLA-A*02","tags":["HLA-A • PRAME"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • Avastin (bevacizumab) • Tecentriq (atezolizumab) • Kimmtrak (tebentafusp-tebn) • brenetafusp (IMC-F106C)"],"overall_status":"Recruiting","enrollment":" Enrollment 727","initiation":"Initiation: 02/25/2020","start_date":" 02/25/2020","primary_txt":" Primary completion: 06/01/2026","primary_completion_date":" 06/01/2026","study_txt":" Completion: 06/01/2026","study_completion_date":" 06/01/2026","last_update_posted":"2024-04-02"}]